Introduction
was set to deliver 1 ms-duration, bipolar, square current pulses at 60 Hz for 1 s at variable current intensities. Depth electroencephalogram (EEG) signals were recorded via the stimulating electrode (except during the 1-s stimulation interval) with a Grass CP511 AC EEG preamplifier (Astro-Med, West Warwick, RI) and stored in digital form using Axotape 9 (Axon Instruments, Foster City, CA).
Kindled seizure activity was assessed using four dependent measures: afterdischarge (AD) threshold, AD duration, severity of behavioral seizures, and behavioral seizure duration. AD threshold refers to the lowest stimulating current intensity (in μA) that induces an AD consisting of a train of EEG spikes at 1 Hz or more lasting for at least 5-s duration with amplitude at least twice the baseline amplitude. AD duration is the total duration of the AD (in s). The severity of behavioral seizures was scored according to Racine (1972b) , with the following designations: stage 0, no apparent change in behavior; stage 1, facial twitching; stage 2, head nodding associated with more severe facial twitching; stage 3, unilateral forelimb clonus; stage 4, rearing; stage 5, rearing and loss of balance. Behavioral seizure duration is the duration (in s) of limbic seizures (stage 1-2) or motor seizures (stage 3-5). Behavioral changes such as immobility with occasional facial twitches that often occurred after the end of motor seizures were not considered in the duration determination.
After the rats recovered from the surgery, kindling began and consisted of three phases: (1) pre-kindling determination of the AD threshold; (2) kindling development, and (3) post-kindling redetermination of the AD threshold (Pinel et al., 1976; Freeman and Jarvis, 1981) . On day 1, AD threshold was determined by delivering a series of stimulations of increasing intensities (starting at 50 μA and increasing in 25% increments every 3-5 min) until AD was triggered. Rats were excluded from the study if a current of 466 μA intensity failed to produce AD on the first day of kindling.
(Rats excluded for this and other reasons, including headmount loss and guide cannula blockage, did not exceed 15% of animals.) During the second phase of kindling, each rat was stimulated daily at a current intensity of 125% of its individual AD threshold value determined on day 1. Daily stimulations continued until the rat exhibited stage 5 seizures during 5 consecutive days or on 8 days out of the last 10 stimulation days. Rats meeting this criterion were considered "kindled." Rats that failed to meet the kindling criterion within 30 stimulations were excluded from the study. During the third phase of kindling, AD threshold was redetermined in the same way as during the first phase of kindling. Threshold was redetermined on several consecutive days until AD threshold and the behavioral seizure score produced by stimulation at the AD threshold were stable and reproducible.
Rats that did not show stable responses to the electrical stimulation at their respective AD thresholds for several consecutive days were excluded from further testing.
Convection-enhanced delivery (CED).
The CED system consisted of a programmable infusion pump (model KDS200, KD Scientific Inc., Holliston, MA), a gas-tight 50µL Hamilton syringe with a 22-gauge needle (Hamilton Company, Reno, NV), a counter-weighted swivel to allow free movement of the rat (Instech Laboratories Inc., Plymouth Meeting, PA), and a 33-gauge infusion cannula (part C315I; Plastics One). All components were connected with thick-wall polyethylene 50 tubing (Plastics One). After gently restraining the rat, the infusion cannula ( Fig. 1 ) was slowly inserted into the brain through the guide cannula. The tip of the infusion cannula extended to a depth 0.5 mm above the tips of the stimulating electrode wires and was maintained at the appropriate depth by a plastic stop at the top of the cannula. The rat was released and placed in a plastic cylinder for the entire infusion. All infusions were performed in conscious and unrestrained animals. After infusion cannula insertion, the brain tissue was allowed to seal around the cannula for a few minutes before initiation of the infusion. Infusions were delivered at a constant rate of 0.25 µL/min, which has previously been determined to be optimal for CED of large molecules into the rat brain (Chen et al., 1999) . The total infusion volume was 5 µL. At the end of the infusion, the cannula was left in place for a few minutes to minimize infusate back-flow and to ensure better distribution of infusate.
Experiments to assess the effects of bolus injection were carried out in an identical fashion except that the infusion rate was 2.5 μL/min.
Evaluation of the effects of test substances on kindling measures and for neurological
toxicity. Effects of test substances on seizure sensitivity in fully-kindled rats were assessed by establishing the AD threshold as described previously and measuring the AD duration, seizure stage and behavioral seizure duration. Following CED infusion of the test substances, animals were stimulated and kindling measures were determined 20 min post-infusion as well as on the subsequent days at 24 h, 48 h, 72 h, 96 h and 1 week post-infusion. Each rat was observed for the occurrence of tremor (rhythmic oscillatory movements of the limbs, head and trunk) or other neurological signs during the test substance infusion, for at least 1 hour after the infusion, and before each subsequent stimulation session. In some animals, stimulation and determination of kindling measures was carried out only during the baseline period and at 7 and 8 days post-infusion.
The effects produced by the test substances on kindling measures were fully reversible within one week after infusion so that rats could be reinfused and retested, allowing the total number of animals used in the study to be minimized. Rats were reused for testing different toxin doses. Also, randomly selected rats from groups previously tested with toxins were reused for testing inactivated ω-CTX-M and carbamazepine. All infusions were separated by at least 14 days. To ensure that there were no interactions between the treatments, all four kindling measures were re-evaluated for several days prior to re-use and compared with the initial baseline values for that animal. Animals were reused only if the AD threshold value and other kindling measures determined upon re-evaluation were close to the baseline values for that animal.
Locomotor activity. At the end of the studies characterizing toxin effects on kindling measures, 18 fully-kindled rats were randomly selected for the locomotor activity testing with a VersaMax Animal Activity Monitoring System (AccuScan Instruments, Columbus, OH). The locomotor activity chamber consisted of a Plexiglas arena (40 cm × 40 cm) surrounded by two sets of infrared light beam sensors detecting horizontal movement of 1.8 cm (at a level of 2.5 cm above the floor) and vertical movement 17.5 cm above the floor. The number of horizontal and vertical beam interruptions (reflecting ambulatory activity and rearing, respectively) were measured during daily sessions lasting 60 min each.
Each rat was exposed to the locomotor-activity chamber for 60 min on 5 successive days to allow habituation. Horizontal and vertical activity trended toward a stable baseline over the 5-day period; the means of the activity counts during the test session on the final two days of the habituation period were taken as the baseline for the infusion studies. On the day after the completion of the 5-day habituation period, each rat received an infusion of a test substance. The parameters of the infusion and other factors including animal handling and external cues were identical to those in experiments. Specifically, effects of each drug treatment are expressed as a change (in percent) from baseline calculated using the following formula: 100 × [(value before treatment) -(value after treatment)]/(value before treatment). Treatment effects with respect to baseline for each rat were calculated separately and then averaged for a group. Statistical analyses of the data from the kindling and locomotor-activity testing were performed by one-way (within a group) and two-way (between groups) repeated measures analysis of variance (ANOVA) after transformation of the percentage change data using arcsine-root transformation. When appropriate, post hoc analysis was performed using Dunnett's test or Tukey's test. Tremor data are expressed as frequencies analyzed by the Fisher's exact probability test.
All calculations were made using SigmaStat (SPSS, Chicago, IL) and GraphPad Prism (GraphPad Software, San Diego, CA). Group differences were considered statistically significant at p < 0.05.
Results
Kindling. The data presented represent the results of experiments with 28 fully amygdala kindled rats. In these animals, daily stimulation at a current intensity of 125% of the AD threshold value resulted in the attainment of the criterion for full kindling (stage 5 seizures) in 15 ± 1 (mean ± S.E.M.) days. The mean AD threshold value in these animals was 197 ± 24 μA on the first day of kindling. All animals in the test group exhibited stable thresholds to elicit stage 5 seizures during the redetermination period. The mean redetermination AD threshold was 96 ± 8 μA and the mean AD duration was 95 ± 4 s. Stimulations at the individual threshold value resulted in behavioral seizures of stage 4.8 ± 0.1 that lasted for 89 ± 3.5 s. The highest doses of ω-CTX-G and ω-CTX-M were associated with transient whole body tremor. In rats treated with ω-CTX-G (0.5 nmol), tremor was evident in 3 of 10 rats within 20 min following the CED infusion and in 9 of 10 rats 1 day after the infusion. In each of the animals that exhibited tremor, the tremor resolved by the third day after the infusion. The 0.5 nmol dose of ω-CTX-M was associated with tremor in 4 of 10 rats immediately after the infusion, but no tremor was apparent on subsequent days in any of the animals. No amygdala depth EEG abnormalities were detected in animals exhibiting tremor indicating that the motor behavior probably did not represent seizure activity. No tremor was observed after infusions of lower doses of the toxins or vehicle.
Effects of CED of ω-CTX-G
Other than tremor, the CED infusions were not associated with any observable effects on neurological function or behavior.
In order to minimize the use of animals, kindled rats were reused for the testing of different toxin doses and vehicle. Thus, each animal received at least four CED infusions (3 doses plus vehicle). During this sequence, the animals received multiple kindling stimulations. To verify that the baseline was stable throughout, mean baseline kindling measures for the complete group of 22 rats determined before each of the four sequential CED infusions were compared. As shown in Fig. 5 , the baseline values in the kindling experiments were stable during the course of repeated infusion and testing (AD threshold: F 3,63 = 1.533, p= 0.215; AD duration: F 3,63 = 1.078, p= 0.365; seizure stage: F 3,63 = 1.501, p= 0.233; behavioral seizure duration: F 3,63 = 0.620, p= 0.604). Thus, it is unlikely that a history of previous testing had an influence on the response to subsequent testing.
Histological examination of the brains from 5 animals tested with full sequences of toxin and vehicle demonstrated that multiple CED episodes were only associated with minimal damage to the amygdala and surrounding brain structures at the site of the infusion cannula-stimulating electrode assembly (Fig. 6A ). An additional 8 rats received bolus infusions of 0.05 nmol ω-CTX-G in the same volume (5 μL) as for CED but at a 10-fold higher infusion rate (2.5 μL/min) using identical implanted infusion cannula-stimulating electrode assemblies. As in the example of Fig. 6B , 7 of these animals exhibited cavitation at the infusion site. The brain of the remaining animal was damaged during removal of the electrode assembly and was not be processed for histology Does continued kindling account for the apparent recovery from the toxin effects? It is possible that the apparent recovery from the effects of toxin exposure over the 1 week period following toxin infusion in the experiments of Figs. 2 and 3 was due to continued kindling resulting from repeated test stimulations and not to a decrease of the toxin effects. In this case, toxin effects on the kindling measures would be expected to be observed at time points beyond the apparent recovery Effects of carbamazepine on kindling measures. In order to determine if CED administration of a conventional non-peptide antiepileptic drug would produce long lasting effects on seizure measures like the peptide toxins, we conducted a series of experiments with the widely used antiepileptic drug carbamazepine. CED infusion of carbamazepine (500 nmol) resulted in a significant increase in the mean AD threshold and decreases in mean seizure stage and mean behavioral seizure duration at the 20 min time point only (p < 0.05) (Fig. 9 ). There were no differences in kindling measures at any of the later time points (24 h to 1 week). Thus, by comparison, CED administration of the peptide toxins is associated with a distinctively long duration of action. Carbamazepine infusion was not associated with any observable adverse neurological or behavioral effects.
Effects of CED infusion of ω-CTX-G and ω-CTX-M on locomotor activity. Animals selected for testing were habituated for five consecutive days to the locomotor activity chamber while recording horizontal and vertical activity. As Fig. 10 shows, the rats quickly habituated to the min (mean ± S.E.M.) following the infusion] followed by rhythmic whole body tremors (beginning 10.8 ± 0.9 min following the infusion). Calculated from the infusion rate and time from infusion onset, the cumulative doses corresponding to the thresholds for locomotor arrest and whole body tremors were 0.013 ± 0.001 and 0.027 ± 0.002 nmol, respectively. The full dose of toxin was associated with rapid, rhythmic shaking of the entire body. The forelimbs and hindlimbs were abducted so that the animal was unable to stand, causing it to rest on its abdomen. Rats experiencing tremor did not engage in normal behaviors, such as cage exploration, ambulation, eating or drinking.
Consequently, there was significant body weight loss (mean ± S.E.M.: 10.3 ± 0.9%) at 24 h compared with the animals that had received the same dose of toxin by CED (body weight increase at 24 h, 0.1 ± 2.1%; p < 0.001 by t-test). Tremors persisted for 24 h, when the animals were euthanized for animal welfare concerns. The overall behavioral syndrome associated with intraventricular infusion of 0.05 nmol ω-CTX-G was much more severe than that observed after CED infusion of 0.5 nmol ω-CTX-G. In the latter instance, tremor was more modest in intensity, usually only evident during handling, and not associated with an interruption of normal behaviors such as exploration or feeding.
Three additional rats were injected intraventricularly with a 0.005 nmol dose of ω-CTX-G, which is below the previously determined threshold for intraventricular toxicity. Accordingly, these animals exhibited no or only mild behavioral effects of the toxin infusion. One of these animals did not exhibit any locomotor disruption or tremor. The second animal showed transient locomotor disruption at the end of the 20 min infusion and no tremor during the entire 24 h observation period.
The third rat did exhibit transient locomotor activity disruption and mild, transient tremor during the infusion; both signs had resolved at 24 h. On average, these 3 rats showed a body weight gain of 3.0 ± 1.8% at 24 h.
Discussion
ω-CTX-G and ω-CTX-M are peptide toxins originally isolated from the venoms of fishhunting cone snails (Olivera et al., 1985; 1987) . The toxins selectively inhibit N-type voltageactivated calcium channels (Ca v 2.2; Dubel et al., 1992) . At central synapses, multiple calcium channel types, including N-type calcium channels, mediate the influx of calcium into presynaptic nerve terminals that is required for neurotransmitter release (Wu and Saggau, 1997). By depressing N-type calcium currents in presynaptic terminals, ω-CTX-G and ω-CTX-M inhibit both excitatory and inhibitory synaptic transmission (Kamiya et al., 1988; Dutar et al., 1989; Horne and Kemp, 1991; Burke et al., 1993; Luebke et al., 1993) . As a result of the effects on calcium channels, the toxins can inhibit epileptiform activity in some in vitro preparations (Boulton and O'Shaughnessy, 1991) . In the present study we sought to determine whether ω-CTX-G and ω-CTX-M infused using the CED method can interfere with the electrical activation of kindled seizures and their subsequent expression electrographically and behaviorally. Our results demonstrate that local CED administration of both toxins at the site of kindling stimulation can produce a prolonged increase in the intensity of electrical stimulation required to activate an electrographic seizure and can depress the seizures elicited.
A key result obtained in the present study is that the toxins can produce long lasting effects on electrical excitability that persist for up to 1 week. The persistent action of the toxins contrasts with the duration of the response to carbamazepine, whose effect on stimulation threshold and on stimulation-induced seizures was apparent at 20 min but not at 24 h. The persistent action of ω-conotoxins has not previously been described. In a study of the analgesic effects of 7-day infusion of ω-CTX-M, Malmberg and Yaksh (1995) found that the action of the toxin had resolved when tested after stopping the infusion. The ability of CED-administered ω-conotoxins to cause long lasting changes in excitability indicates that the toxin could have diverse applications as research tools. They may also have potential clinical applications. Two factors could account for the prolonged duration of action of the toxins in these experiments. The binding of ω-CTX-G and ω-CTX-M to N-type calcium channels under ordinary condition is extremely stable and is generally considered to be irreversible (Cruz and Olivera, 1986; Grantham et al., 1994; Fox, 1995) . If the turnover of N-type calcium channels is low (or if toxin binding inhibits turnover), then the irreversible nature of toxin binding could account for the persistent blocking action of the toxin. In this case, recovery would result from resynthesis of new channel protein. Little is known about the stability of N-type calcium channels at central nervous system synapses. Our results are compatible with the possibility that channel turnover is slow and occurs over the course of days. We note that under this scenario the channel turnover rate may not necessarily be the dominant rate accounting for recovery from the toxin effects inasmuch as dissociation of toxin from N-type calcium channels, while slow, could nevertheless occur over the time course of days. The second factor that could contribute to prolonged toxin action is the inability of toxin molecules to leave the site of deposition in the extracellular space following CED infusion. Carbamazepine is a strongly hydrophobic molecule (log P of 2.69 by XLogP; Wang et al., 1997) which readily diffuses across biological membranes. Thus, it can easily leave the site of deposition. Accordingly, even though a relatively large amount of carbamazepine was delivered in the CED experiments, its effects dissipated rapidly. By contrast, ω-CTX-G and ω-CTX-M are hydrophilic [grand average of hydropathicity (GRAVY) values, -0.893 and -0.464, respectively; Kyte and Doolittle, 1982] and would be expected to remain in the extracellular space at the site of deposition. Although the toxins are susceptible to cleavage by endopeptidases and exopeptidases at multiple peptide bonds, cerebrospinal fluid exhibits minimal hydrolytic activity for the peptides, so that local degradation is not expected to limit the duration of the functional activity.
The fact that we observed a prolonged duration of action of the toxins when they were administered by CED whereas the duration was not prolonged with instillation into the cerebrospinal fluid in the study of Malmberg and Yaksh (1995) suggests that slow toxin clearance may be of greater importance than slow dissociation from the target site as a determinant of the long duration of action of the toxins.
In binding studies, ω-CTX-G and ω-CTX-M have been shown to compete for the same target in brain, which represents the N-type calcium channel α 1B subunit (Ca v 2.2) (Feng et al., 2003) . The kinetics of binding and affinity of the two toxins for expressed recombinant rat Ca v 2.2 calcium channel subunits is similar (K D ∼ 100 nM). Mutagenesis studies have indicated that the two toxins bind to overlapping domains on the channel, but the recognition sites do not share identical structural determinants (Nielsen et al., 2000; Feng et al., 2003) . We found that the efficacy and time-course of action of the toxins were similar, except that ω-CTX-G produced a significant effect on AD threshold at the 0.05 nmol dose whereas the effects of ω-CTX-M at this dose did not reach significance (Table   1 ). In a study with audiogenic seizure susceptible mice, intraventricularly administered ω-CTX-G protected against seizures whereas ω-CTX-M did not (Jackson and Scheideler, 1996) , indicating that as in our results ω-CTX-G may have greater anticonvulsant potency than ω-CTX-M. However, upon intraventricular administration, both toxins induced intense shaking at very low doses. We confirmed that intraventricular infusion of 0.05 nmol ω-CTX-G, a dose that was devoid of any gross behavioral effects when delivered by CED, caused profound behavioral disruption, including persistent wholebody tremor. Thus, untargeted administration of the conotoxins by instillation into the cerebrospinal fluid is not likely to be a useful therapeutic approach. In contrast, our results indicate that local CED delivery of the toxins can protect against seizures with reduced or no untoward neurological side effects, highlighting the potential of local CED delivery for epilepsy therapy.
To confirm that the effects of toxin infusion were due to functional blockade of N-type calcium channels, we demonstrated that CED infusion of proteolyzed ω-CTX-M, which has less than 1% of the binding affinity of the native toxin and is inactive physiologically (Nadasdi et al., 1995) , had no effect on kindling measures. In an additional series of control experiments, we excluded superkindling as an explanation for the apparent recovery from the toxin effects over the 1-week course of the CED studies. Superkindling is a phenomenon whereby continued daily kindling stimulations cause a progressive decrease in the AD threshold, presumably due to continuing kindling (Racine, 1972a) . Superkindling could lead to an apparent diminution in activity of the toxin.
However, in experiments where we did not apply kindling stimulations until the 7th day after the toxin infusion, we found no change in any kindling measures on days 7 and 8 indicating that the toxin effect decreases even when kindling stimulations are not applied.
Although toxin infusion produced a remarkably long-lasting effect on kindling measures, there was no evidence that the repeated CED infusions or episodes of toxin exposure caused functionally significant tissue damage. Histological examination after several cycles of toxin infusion and multiple kindling stimulations failed to detect any evidence of tissue damage at sites beyond the tract caused by the physical placement of the infusion cannula-stimulating electrode assembly. In addition, as shown in Fig. 4 , baseline kindling measures were stable over multiple CED infusions of vehicle and toxins at different doses. Thus, repeated CED infusion of the toxins did not produce permanent alterations in the electrical excitability properties of the brain at the infusion site.
Moreover, there was no indication that the toxins had antiepileptogenic properties to reverse the epileptic state generated by the initial kindling stimulations.
Carbamazepine was highly protective when administered by CED infusion, consistent with its well-recognized activity against amygdala kindled seizures in rats when administered systemically (Albertson et al., 1984) . The peak action of carbamazepine occurred earlier than the toxins and its duration was dramatically shorter. The more rapid onset and recovery from carbamazepine are likely due to its ability to diffuse to the target within the infusion zone and then leave the infusion zone, as discussed above. Indeed, carbamazepine has a short duration of action when it is administered systemically or by the intracerebroventricular route in amygdala-kindled rats (Albertson et al., 1984; Barcia et al., 1999) . Although the minimum effective dose of carbamazepine was not determined, carbamazepine appears to be markedly less potent than the toxins. The high potency of the ω-conotoxins might be advantageous in a clinical application in which an implanted pump of limited capacity is used to deliver the therapeutic agents.
ω-CTX-G and ω-CTX-M are well recognized to cause "shaking" when injected intracerebroventricularly in mice and, in fact, were initially isolated from cone snail venom on the basis of this activity (Olivera et al., 1985; Miljanich and Ramachandran, 1995) . In our CED experiments, the highest doses of ω-CTX-G and ω-CTX-M were associated with tremor in some animals, but lower doses, even those that had long lasting effects on kindling measures, did not cause tremor. Thus, in contrast to the situation when the toxins are instilled into the cerebrospinal fluid, when administered by CED tremor can be dissociated from therapeutic activity. There were no other observable neurobehavioral effects of the CED toxin infusions. Specifically, the toxins did not cause any significant changes in locomotor activity during the 96 h period after CED infusion. ω-CTX-G was associated with more prolonged tremor than ω-CTX-M, further supporting the view that it is modestly more potent. Since toxin effects on kindling measures could be obtained in the absence of tremor, we presume that the tremor obtained with high toxin doses is due to leakage of the toxins from the amygdala infusion site. Such leakage is likely to be a particular problem in animals with small brains inasmuch as the distribution of substances administered by CED can be more effectively controlled in larger brain volumes (Lieberman et al., 1995; Lonser et al., 2002) .
In conclusion, our study provides the first experimental evidence that brief (20-min), localized CED infusions of ω-CTX-G and ω-CTX-M can produce prolonged alterations in brain excitability at the site of the infusion that persist for up to 1 week. Moreover, our results raise the possibility that the CED technique could have utility in suppressing focal seizures. Although we used ω-conotoxins to demonstrate the potential of the CED method, CED is equally applicable to other large blood-brain barrier impermeable anticonvulsant substances or biological agents, including other anticonvulsant peptides, gene vectors or cell grafts. In our experimental paradigm, seizures were elicited by electrical stimulation. Further studies are required to demonstrate that CED is similarly effective in suppressing spontaneous seizures emanating from an endogenous seizure focus. If this can be confirmed, CED infusion could eventually be used as a presurgical diagnostic tool to determine the functional activity of a localized epileptic brain region and the consequences of its later removal. In addition, the method might also be used therapeutically as an alternative to resective surgery in intractable focal epilepsies or where systemic toxicities or the teratogenicity of systemically administered antiepileptic drugs must be avoided. Legends for Figures   Fig. 1 . Components of the cannula-bipolar stimulating electrode assembly system used for kindling stimulation and recording, and for CED delivery of solutions into the basolateral amygdala. The combination guide cannula and bipolar stimulating assembly is shown to the right. The guide cannula passes through the threaded left-most pedestal; stimulating electrodes are affixed diametrically opposed to the exterior of the guide cannula below the pedestal. The two wire electrodes pass to the right-most pedestal containing pin connectors to allow electrical connection to the kindling stimulator. The dummy cannula wire-cap assembly is shown to the left. The plastic cap is internally threaded to match the treads of the pedestal of the cannula-electrode assembly. The CED cannula is shown in the center. The plastic stop maintains the tip of the CED cannula 0.5 mm above the tips of the stimulating electrode wires. Table 1 . Table 1 . Bottom, the adjacent silver stained section shows some staining in the right striatum, thalamus, and internal capsule, indicating neuronal disintegration. There is no damage apparent in the amygdala. B, Brain obtained from a rat infused with 0.05 nmol ω-CTX-G at a rate of 2.5 μL/min (10-fold greater than for CED). Tracks of the stimulating electrode wires are seen to extend into the right basolateral amygdala and a cavity is present above the nucleus. A second cavity is present in the alveus due to damage from the guide cannula and tracking of the infused solution up the cannula. Cavitation was observed in 7 of 8 rats treated in a similar fashion. 
